Open Access
Issue
E3S Web of Conf.
Volume 553, 2024
2024 International Conference on Ecological Protection and Environmental Chemistry (EPEC 2024)
Article Number 05032
Number of page(s) 5
Section Medical Treatments and Therapies
DOI https://doi.org/10.1051/e3sconf/202455305032
Published online 24 July 2024
  1. HIV.gov, Global Statistics, (2023) [Google Scholar]
  2. E. De. Clercq, J CLIN VIROL,Volume 22, Issue 1, Pages 73-89,ISSN 1386-6532,(2001) [CrossRef] [PubMed] [Google Scholar]
  3. J.E. Kaplan, MD, Antiretrovirals: HIV and AIDS Drugs, (2023) [Google Scholar]
  4. AB.Bhatti,M.Usman,V.Kandi. C.Cureus. Mar1;8(3) :e515. (2016) [Google Scholar]
  5. MA.Fischl,DD.Richman, MH.Grieco, Gottlieb MS, PA.Volberding, OL.Laskin, JM.Leedom, JE. Groop man, D.Mildvan, RT. Schooley, et al. N Engl J Med. 317(4):185-91.( 1987) [CrossRef] [PubMed] [Google Scholar]
  6. A. K. Pau, J. M. George, INFECT DIS CLIN N AM,Volume 28, Issue 3, Pages 371-402,( 2014) [CrossRef] [Google Scholar]
  7. A.Kapoor,CS.Tan.Curr,HIV/AIDSRep. 17(5):499-506. (2020) [Google Scholar]
  8. Chen Z, Julg B. Therapeutic Vaccines for the Treatment of HIV. Transl Res. 223:61-75.( 2020) [Google Scholar]
  9. CL.Day,DE.Kaufmann,P.Kiepiela,JA.Brown, ES.Moodley, S.Reddy, EW.Mackey, JD.Miller, AJ.Leslie, C. DePierres, Z.Mncube, J.Duraiswamy, Zhu B, Q. Eichbaum, M.Altfeld, EJ.Wherry, HM.Coovadia,PJ.Goulder,P.Klenerman, R.Ahmed, GJ.Freeman, BD. Walker. Nature 443:350–4. [PubMed] [Google Scholar]
  10. L.Trautmann,L.Janbazian,N.Chomont,EA.Said, S.Gimmig,B.Bessette,MR.Boulassel,E.Delwart, H.Sepulveda, RS.Balderas, JP.Routy,EK.Haddad, Sekaly RP. Nat Med 12:1198–202. (2006) [CrossRef] [PubMed] [Google Scholar]
  11. Churdboonchart V, Moss RB, Sirawaraporn W, Smutharaks B, Sutthent R, Jensen FC, Vacharak P, Grimes J, Theofan G, Carlo DJ. AIDS 12:1521–1527. (1998) [CrossRef] [PubMed] [Google Scholar]
  12. CM.Tsoukas,J.Raboud,NF.Bernard, JSG.Montaner, MJ.Gill,A.Rachlis,IW.Fong,W.Schlech,O.Djurdje v,J.Freedman,R.Thomas,R.LafreniÈRe,MA.Wainb erg,S.Cassol,M.O’Shaughnessy,J.Todd,F.Volvovitz,GE.Smith.AIDS Research and Human Retroviruses 14:483–490. (1998) [CrossRef] [PubMed] [Google Scholar]
  13. Y.Voronin, H.Zinszner, C.Karg, et al. Vaccine. 33(10):1243–1249. (2015) [CrossRef] [Google Scholar]
  14. R.C.Gallo, Montagnier L.NEJM, 349(24): 2283-2285. (2003) [Google Scholar]
  15. MM.Lederman, PM.Cannon, JS.Currier, CH.June, HP. Kiem, DR.Kuritzkes, SR.Lewin, DM.Margolis, JM.McCune, JW.Mellors,TW.Schacker, RP.Sekaly, P.Tebas, BD.Walker, DC. Douek. Pathog Immun. Spring;1(1):154-164. (2016) [CrossRef] [PubMed] [Google Scholar]
  16. P.Pitisuttithum, M.A. Marovich.Expert Review of Vaccines, 19:2, 133-142.(2020) [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.